Indian state plans to construct drug manufacturing plants
Kerala State Health Department official was quoted by Pharmabiz as saying that detailed modalities were being worked out and feasibility studies were being done to set drug plants.
Novartis has signed an agreement to purchase Myricx Bio, a UK-based biotechnology company, in a transaction valued at up to $1.5bn.
The vaccine combined Immunovaccine’s DepoVax adjuvanting technology and Weill Cornell’s novel anti-cocaine vaccine (dAd5GNE). Immunovaccine chief science officer Dr. Marc Mansour said the company’s delivery system holds the
Scilligence’s informatics products usage will enhance knowledge sharing and productivity of researchers in the discovery and development of small molecule and biologics therapeutics. In addition, Scilligence’s proprietary technology